Pennsylvania set to ban supervised drug use sites, in setback for harm reduction
Pennsylvania lawmakers are set to pass a new ban on supervised drug consumption, effectively ending…
Author: STAT
Putting radiation to the test to heal irregular heartbeat
ST. LOUIS — Doctors are zapping the heart with radiation normally reserved for cancer, a…
‘We went from almost no lockdowns to daily lockdowns’: The mental health crisis inside California women’s prisons
Liz Lozano has been incarcerated since 1995. Having spent over 20 years at the Central…
Opinion: There’s a surprisingly easy way to avoid a huge number of major amputations
More than 400 Americans undergo major amputation of a leg, either above or below the…
To prevent preeclampsia, experts push for broader blood pressure testing at home
Eleni Tsigas likens her first experience with preeclampsia to a plane crash. She was in…
STAT+: FDA warns of security vulnerability in Illumina’s DNA sequencing machines
The Food and Drug Administration warned health care providers Thursday that a security vulnerability in…
Biden officials propose slate of Medicaid transparency changes
WASHINGTON — The Biden administration on Thursday rolled out proposals to set national standards for…
Listen: Explaining the E.U.’s pharma overhaul, Lilly’s booming business, & a long-awaited drug approval
Is a specter haunting Europe? Will Eli Lilly usurp Johnson & Johnson? And what does…
Vast sequencing project begins to unlock human genome’s secrets — by deciphering other mammals’ DNA
Despite decades of advancements in genomics, we still don’t know what most of our DNA…
GoodRx hires former tech exec as CEO, Amazon shutters Halo, and Teladoc beats expectations
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
Virtual Event: Breakout Stars in Science
Editor’s Note: A livestream of the event will be embedded below at 1 p.m. ET….
STAT+: Pharmalittle: Lilly’s Mounjaro helped people lose 15.7% of body weight; Sanofi earnings boosted by Dupixent
Good morning everyone, from STAT reporter Andrew Joseph here filling in for Ed. Or, if…
STAT+: Eli Lilly’s Mounjaro succeeds in second weight-loss study, paving way for FDA review
The drug giant Eli Lilly said Thursday that its diabetes drug Mounjaro helped patients with…
STAT+: Six months after launch, Bert Vogelstein’s latest blood testing startup gets acquired for $450 million
Six months after launch, a startup founded by three leaders in the blood testing field…
A research team airs the messy truth about AI in medicine — and gives hospitals a guide to fix it
In public, hospitals rave about artificial intelligence. They trumpet the technology in press releases, plaster…
STAT+: Pharma executives flood Bill Cassidy with campaign cash
WASHINGTON — Sen. Bill Cassidy’s new perch as the top Republican on the Senate health…
.jpg)
STAT+: Health insurance CEOs set another record for pay in 2022
Business has never been better for the largest health insurers in the country, which led…
Opinion: A judge’s infuriating ruling on vaccination puts Mississippi’s children at risk
Mississippi consistently ranks last or near-last in the United States on measures of health. But…
STAT+: FDA approves Seres microbiome drug, as field advances
The Food and Drug Administration on Wednesday approved a new drug from Seres Therapeutics that…
STAT+: Facing headwinds, Teladoc tests its bet on whole-person care
Virtual care incumbent Teladoc beat Wall Street revenue estimates in the 2023’s first quarter —…
STAT+: Alnylam’s ‘upstream’ Alzheimer’s treatment shows early promise
An early-stage Alzheimer’s disease treatment from Alnylam Pharmaceuticals showed promising signs of benefit in a…
STAT+: Early findings in gene therapy death suggest CRISPR was not the cause
In February, four months after the first patient in a designer CRISPR therapy suddenly died,…
STAT+: Kaiser Permanente, Geisinger to merge into national health system
Kaiser Permanente and Geisinger have agreed to combine into a new national not-for-profit system that…
STAT+: Another powerful congressional committee is ready to take on PBMs
WASHINGTON — House Oversight Committee Chairman James Comer plans to hold a hearing on the…
STAT+: EU releases proposed pharma overhaul, cutting period of market exclusivity
LONDON — The European Commission on Wednesday unveiled a long-awaited proposed update for how the…
STAT+: Pharmalittle: EU unveils sweeping pharma reforms; new eye drug helps Roche beat the street
Hello, everyone. Damian Garde here, filling in for Ed Silverman once more as the working…
STAT+: RNA startup Orbital cinches $270 million investment
A new biotech founded by veterans of Alnylam Pharmaceuticals, Beam Therapeutics, ARCH Venture Partners, and…
Led by students, a nascent climate movement is taking hold in medical education
When Cecilia Sorensen was an emergency medicine resident practicing at Denver Health in Colorado a…
Opinion: STAT+: At-home clinical trials are the future
In the early days of the Covid-19 pandemic, much of the clinical trials industry came…
STAT+: Medicare official insists drug price negotiation will consider value of drugs
WASHINGTON — When Medicare starts negotiating drug prices, it will take into account how important…
Telehealth companies that provide abortion pills grapple with regulatory uncertainty
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: FDA approves new treatment from Biogen for rare form of ALS
The Food and Drug Administration on Tuesday granted conditional approval to a new treatment for…
STAT+: Sens. Bernie Sanders, Bill Cassidy reach deal on PBM, generic reform
WASHINGTON — Senate health committee leaders Bernie Sanders and Bill Cassidy on Tuesday announced an agreement…
With little FDA oversight, melatonin supplements vary widely in actual dosage, study finds
WASHINGTON — Consumers turning to melatonin gummies to get some help falling asleep might be…
STAT+: Pharmalittle: Novartis boosts its sales and profit outlook; Biogen trims its drug pipeline
Good morning, one and all. Damian Garde here, filling in for Ed Silverman on an…
STAT+: Morphic study shows promise — and blockbuster potential — for a pill to treat ulcerative colitis
Morphic Therapeutic said Tuesday that an experimental oral medicine induced complete remissions in 26% of…
‘There’s a huge fatphobia problem in the eating disorder world’: Even in treatment, weight stigma fails patients
This is part of a series about new obesity drugs that are transforming patients’ lives,…
Opinion: Why involuntary treatment for addiction is a dangerous idea
As the overdose crisis rages on and the pandemic-fatigued public runs low on empathy, there…
STAT+: Maryland pushes first-of-its-kind bill to promote alternatives to animals in biomedical research
Amid a push to use fewer animals in medical research, Maryland is on the verge…
STAT+: Pharmalittle: Weight-loss drug makers lobby Congress for Medicare coverage; Europe braces for new pharma legislation
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Bluebird submits sickle cell gene therapy to FDA for approval
Gene therapy developer Bluebio Bio said Monday that it has submitted a long-awaited application asking…
STAT+: How a small hospital in Nebraska has thrived through the pandemic
Great Plains Health is a small hospital system in a part of Nebraska surrounded by…
Opinion: How small vaccine stockpiles can stop outbreaks of infectious disease from becoming big
Marburg could soon become the second virus in the past year to have experimental vaccine…
Q&A: Chronicling the failures of the U.S. response to Covid
A new book on the U.S. response to the Covid-19 pandemic paints a picture of…
Opinion: How journalists can cover RFK Jr.’s antivax presidential run responsibly
Of course it was news when Robert F. Kennedy Jr. announced that he is running…
STAT+: ‘A tug of war’: Europe braces for new legislation with far-reaching impacts on pharma and patients
After more than two years of planning, the European Commission on Wednesday will release long-awaited…
Dying patients protest looming telehealth crackdown
At age 93, struggling with the effects of a stroke, heart failure and recurrent cancer,…
Supreme Court maintains access to abortion pill mifepristone, at least for now
WASHINGTON — The U.S. Supreme Court on Friday ruled 7-2 that a commonly used abortion…
STAT+: HCA bags big first quarter as patient volumes soar
Patient volumes are back in a big way, at least for the country’s largest for-profit…
STAT+: Pharmalittle: Lilly expects Medicare to back down on Alzheimer’s drug coverage; key senators change insulin cap proposal
And so, another working week will soon draw to a close. Not a moment too…